CReATe: Investigating Neurofilament Light Chain as a Biomarker for Amyotrophic Lateral Sclerosis
Jan 20, 2023 ·
2m 38s
![CReATe: Investigating Neurofilament Light Chain as a Biomarker for Amyotrophic Lateral Sclerosis](https://d3wo5wojvuv7l.cloudfront.net/t_square_limited_480/images.spreaker.com/original/8bf2b20a450f0bdef3978317f49fd90d.jpg)
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
New research from the Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium. This summary is based on a paper published in the journal Brain on October...
show more
New research from the Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium. This summary is based on a paper published in the journal Brain on October 31, 2022, titled "Neurofilament light chain in drug development for amyotrophic lateral sclerosis: a critical appraisal."
Read the paper here: https://academic.oup.com/brain/advance-article/doi/10.1093/brain/awac394/6780887?login=false
Learn more about CReATe: https://www1.rarediseasesnetwork.org/cms/create/
show less
Read the paper here: https://academic.oup.com/brain/advance-article/doi/10.1093/brain/awac394/6780887?login=false
Learn more about CReATe: https://www1.rarediseasesnetwork.org/cms/create/
Information
Author | RDCRN |
Website | - |
Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company